11,000-Patient study seeks better sleep apnea care
NCT ID NCT07339371
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 11,100 adults with sleep-disordered breathing for up to 5 years. Researchers will collect health data and samples to find better ways to predict risks and tailor treatments. No new drug or device is being tested; participants receive standard care like CPAP or lifestyle advice.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better guidelines for managing sleep-disordered breathing and help doctors personalize treatment for each patient.
- What could go wrong
- This is an observational study, so it cannot prove what treatments work best. Results may take years and might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 11,100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of adult patients presenting to the outpatient or inpatient departments of participating clinical centers across China who have completed or are scheduled for sleep breathing monitoring for suspected or confirmed SDB.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years. * Patients who have completed sleep breathing monitoring within 1 month prior to enrollment. * Capable of providing signed informed consent. Exclusion Criteria: * Estimated life expectancy of less than 3 months. * Refusal to participate in the study. * Inability to cooperate with baseline data collection or follow-up evaluations.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sleep-disordered breathing (SDB) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart mask aims to measure blood oxygen through your face
- Can a week at sea level ease sleep and oxygen strain for High-Altitude heart patients?
- Can a short trip to sea level reset sleep and oxygen for high-altitude dwellers?
- Dentists may soon screen kids for sleep apnea with a simple questionnaire
- Fixing heart valves may improve sleep apnea, new study investigates
- Can a sleep machine stop heart rhythm problems after ablation?